Wojciech P.
- Country
- Poland
- Department
- Oddział Kliniczny Pulmonologii i Alergologii z Pododdziałem Chorób Wewnętrznych
Research Overview
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
- A Phase 2b Dose-Ranging Study of Oral KT-621 in Adults with Uncontrolled Moderate to Severe Eosinophilic Asthma
- A Phase IIb, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Zampilimab in Participants with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 289 of 629 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in treating various pulmonary disorders, with particular focus on inflammatory and fibrotic lung conditions.
- Idiopathic Pulmonary Fibrosis
- Pulmonary Sarcoidosis
- Chronic Obstructive Pulmonary Disease
- Chronic Cough Conditions
Their research encompasses both progressive and inflammatory lung diseases, including extrapulmonary manifestations.
Inflammatory Bowel Conditions
The investigator has extensive experience in treating inflammatory bowel disorders, focusing on various presentations and severities.
- Ulcerative Colitis
- Crohn's Disease
- Moderate to Severe IBD
Their work includes evaluation of novel therapeutic approaches for inflammatory bowel conditions.
Respiratory Inflammation
The investigator demonstrates particular interest in inflammatory respiratory conditions and their management.
- Asthma
- Interstitial Lung Disease
- Systemic Sclerosis-Associated Lung Disease
Their research includes innovative approaches to treating both acute and chronic respiratory inflammation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.